Diabetes, Heart and Cardiovascular Diseases News Chronicle Diabetes, Cardiovascular and Heart Diseases. Article 29
Published on July 23, 2016 at 9:05 AM


Risks With Too Little Or Too Much Sleep

A new study led by Femke Rutters found that too much or too less sleep increases risk for type ii diabetes (T2D) in future, a phenomena associated only with men. Researchers observed sleep duration and diabetes risk factors of 788 individuals aged between 30 and 60 years, from 14 European countries. The men who slept least time or long time had increased risk of inability to process glucose and were at higher blood sugar levels. The study concludes that even though an individual is healthy, he is at risk if he sleeps too long hours or sleeps too little hours. Healthy sleep duration is between 7.5 to 9 hours. Femke Rutters, VU Medical Center, Amsterdam is the senior author of the study and the study findings were published in the Journal of the Clinical Endocrinology & Metabolism.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Risks With Adrenal Tumors NFATs
2. Risks With Heart Disease

 

Treatment For NASH With Pioglitazone

A three year study finding published the Annals of Internal Medicine says researchers have found treatment for fatty liver disease nonalcoholic steatohepatitis (NASH) in diabetes patients. Researchers found 58 percent individuals experienced reduced NASH activity and 51 percent individuals have no NASH activity after getting treatment with Pioglitazone diabetes drug. 2 to 5 percent of US citizens are being affected with NASH and its development is a risk factor to cirrhosis and liver cancer. Diplomat specialty pharmacy is expecting approval in 2016 and treatment may start in 2017. Currently NASH is not approved by FDA.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Device To Predict Diabetes
2. Benefits With Coffee Consumption
3. Risks To Heart Attack And Diabetes Before Menopause

 

Treatment For Diabetic Macular Edema (DME) With Bevacizumab Drug

Part of the retina is called macula. Macula gives us most detailed vision abilities. High sugar levels damages blood vessels in retina and leaked fluids accumulates in macula and impairers our vision. This disease is called Diabetic macular edema (DME). DME can be treated with any of the following drugs

A new study published in JAMA Ophthalmology found that bevacizumab drug is cheaper compared with aflibercept (31 times more expensive) and ranibizumab (20 times more expensive) but aflibercept was most effective in treating DME.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Study To Treat Diabetic Foot Ulcers
2. Risks With Fine Dust
3. Risks With Heart Attack

 

Treatment For Nonalcoholic Steatohepatitis NASH With Pioglitazone

Clinical trial led by Dr Kenneth Cusi belonging to University of Florida found that Pioglitazone diabetic drug is safe and effective in treating some patients suffering with NASH liver disease. There are no medications available to treat this disease. NASH or nonalcoholic steatohepatitis is a silent liver disease caused due to fat buildup in the liver. NASH can lead to liver cancer or cirrhosis. Obese individuals having type 2 diabetes (T2D) are at risk and early diagnosis and treatment is required for this disease. The findings are published in journal Annals of Internal Medicine.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Device To Release Drugs In Eye
2. Benefits With Alcohol Free Blueberry Blackberry Wine
3. Study Of Liraglutide Drug On Heart Failure

 

Risks With Fat Buildup In Liver NASH
33 percent of Americans are obese and it is expected to be 50 percent by 2030. Nonalcoholic Fatty Liver Disease (NAFLD) is a chronic liver disease which is associated with diabetes and obesity. This is caused because of the accumulation of extra fat in the liver. Severe form of NAFLD is called Nonalcoholic Steatohepatitis (NASH), a "silent" liver disease. NASH causes liver inflammation and causes liver tissue injury and finally damages liver and causes liver cancer or failure of liver or death. Studies could not find out the causes for NASH but the some of the risk factors are

No medication available for the treatment of NASH. Individual with risk factors can prevent the disease with lifestyle changes, diet control and regular exercise.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Discovery Of Low Fat Chocolate
2. Risks With Liver Disease
3. SR10171 Drug For The Treatment Of Bone Disease And Diabetes

 

Treatment For Diabetic Eye Problem With anti-VEGF Injection Drugs
Clinical trials shows that prescribed treatment option for diabetic macular edema (DME) includes injecting anti-VEGF agents. But a study done by Brian L VanderBeek MD MPH (Physician, the Hospital of the University of Pennsylvania), found that most of the patients were under treated or not treated early to prevent the development of vision loss. Patients are taking on the average 3.6 anti-VEGF injection drugs when 9 to 10 injections were prescribed.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Risks To Diabetes Induced Cognitive Impairment
2. About Coronary Heart Disease (CHD)

 

Categories

Sitemap 1   Sitemap 2   Sitemap 3   Sitemap 4

 

Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.